COSCIENS Biopharma, Inc. (CSCI.TO)
8.88
+0.13
(+1.49%)
CAD |
TSX |
Oct 05, 15:59
COSCIENS Biopharma Profit Margin (Quarterly) : -6.43% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.43% |
| March 31, 2026 | -9.69% |
| December 31, 2025 | -123.6% |
| September 30, 2025 | -122.7% |
| June 30, 2025 | -94.08% |
| March 31, 2025 | -192.8% |
| December 31, 2024 | -202.6% |
| September 30, 2024 | -307.6% |
| June 30, 2024 | -60.85% |
| March 31, 2024 | -68.11% |
| December 31, 2023 | -129.0% |
| September 30, 2023 | -39.75% |
| June 30, 2023 | -61.78% |
| March 31, 2023 | -200.0% |
| December 31, 2022 | -501.0% |
| September 30, 2022 | -183.9% |
| June 30, 2022 | |
| March 31, 2022 | -174.0% |
| December 31, 2021 | -302.7% |
| September 30, 2021 | -183.6% |
| June 30, 2021 | -131.6% |
| March 31, 2021 | -87.41% |
| December 31, 2020 | -55.41% |
| September 30, 2020 | -887.3% |
| June 30, 2020 | -5.07K% |
| Date | Value |
|---|---|
| March 31, 2020 | 71.47% |
| December 31, 2019 | -5.58K% |
| September 30, 2019 | -117.0% |
| June 30, 2019 | |
| March 31, 2019 | -13.27K% |
| December 31, 2018 | -368.3% |
| September 30, 2018 | -378.4% |
| June 30, 2018 | -1.55K% |
| March 31, 2018 | 58.50% |
| December 31, 2017 | -271.9% |
| September 30, 2017 | -4.00K% |
| June 30, 2017 | -1.05K% |
| March 31, 2017 | -1.58K% |
| December 31, 2016 | -2.70K% |
| September 30, 2016 | -2.25K% |
| June 30, 2016 | -7.30K% |
| March 31, 2016 | -1.52K% |
| December 31, 2015 | -9.85K% |
| September 30, 2015 | -8.90K% |
| June 30, 2015 | -7.69K% |
| March 31, 2015 | -13.20K% |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Spectral Medical, Inc. | 53.30% |
| Resverlogix Corp. | -- |
| Theratechnologies, Inc. | -- |
| Restart Life Sciences Corp. | -307.0% |
| Covalon Technologies Ltd. | 27.99% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -47.16% |
| Return on Assets | -19.84% |
| Return on Invested Capital | -38.43% |
| Gross Profit Margin (Quarterly) | 55.27% |
| Operating Margin (Quarterly) | 13.43% |
| Return on Net Operating Assets | -30.13% |